Resumen

JAVE C, H. Oswaldo; CONTRERAS M, Mariana  y  HERNANDEZ U, V. Andrés. Situation of multi-drug-resistant tuberculosis in Peru. Acta méd. Peru [online]. 2017, vol.34, n.2, pp.114-125. ISSN 1728-5917.

The history of interventions and the epidemiological history of the hyperendemicity of multi-drugresistant tuberculosis (MDRTB) encompasses the 1987-2016 period, and it still continues. The first problem was to recognize its transmissibility and the need to measure its real magnitude. During the 90s, the condition expanded because its extent was underestimated. During the first decade of the new millennium, universal access for susceptibility testing was granted, with the support of the Technical Unit of the former National Tuberculosis Control Program of the Peruvian Ministry of Health. During the whole period, different therapy schedules have been tested, with dissimilar results, and only individualized regimens with at least three new drugs were shown to be persistently efficacious. Thanks to the support of the World Fund, patients were able to get universal access to therapy. Both interventions had an impact upon the hyperendemic trend, and the expansion of this was stopped. However, some limitations occurring in the latter years, including an underestimation of the real magnitude of the problem, have led to a rebound in this condition. Consequently, Peru is the country with the most severe cases of MDR TB and extremely resistant tuberculosis in the Americas

Palabras clave : Tuberculosis, multidrug-resistant; Tuberculosis; Epidemiology.

        · resumen en Español     · texto en Español     · Español ( pdf )